TrademarkDir
IMMUNOPHERESIS
LIVE

Serial Number

88127544

Owner

IMMUNICOM INC.

Attorney

Richard W. Knight

First Use Date

Jan 31, 2019

Filing Date

Sep 21, 2018

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

IMMUNOPHERESIS Trademark

Serial Number: 88127544 • Registration: 6366355

IMMUNOPHERESIS is a trademark filed by IMMUNICOM INC. on September 21, 2018. The trademark is classified under Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

IMMUNICOM INC. (3 trademarks)

San Diego, CA 92121

Entity Type: 03

Trademark Details

Filing Date

September 21, 2018

Registration Date

May 25, 2021

First Use Anywhere

January 31, 2019

First Use in Commerce

January 31, 2019

Goods & Services

research in the field of immunology, immunotherapy, and blood filtering for medical purposes including treatment of cancer, inflammatory diseases, and autoimmune diseases

medical devices for performing immunotherapy and blood filtering for medical purposes including treatment of cancer, inflammatory diseases, and autoimmune diseases

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
May 25, 2026 REM1
CORRECTION UNDER SECTION 7 - PROCESSED
Jan 23, 2022 COC.
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jan 22, 2022 APRE
TEAS SECTION 7 REQUEST RECEIVED
Sep 17, 2021 ES7R
REGISTERED-SUPPLEMENTAL REGISTER
May 25, 2021 R.SR
LAW OFFICE PUBLICATION REVIEW COMPLETED
Apr 21, 2021 PREV
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Apr 12, 2021 CNTA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 7, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 7, 2021 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Apr 3, 2021 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Oct 13, 2020 GNFN
FINAL REFUSAL E-MAILED
Oct 13, 2020 GNFR
FINAL REFUSAL WRITTEN
Oct 13, 2020 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 16, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 16, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 11, 2020 TROA
NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Mar 17, 2020 AAUA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 16, 2020 GNRN
NON-FINAL ACTION E-MAILED
Mar 16, 2020 GNRT
NON-FINAL ACTION WRITTEN
Mar 16, 2020 CNRT
USE AMENDMENT ACCEPTED
Mar 16, 2020 IUAA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 13, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 13, 2020 CRFA
AMENDMENT TO USE PROCESSING COMPLETE
Feb 8, 2020 AUPC
USE AMENDMENT FILED
Feb 8, 2020 IUAF
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 7, 2020 TROA
TEAS AMENDMENT OF USE RECEIVED
Feb 7, 2020 EAAU
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 8, 2019 GNRN
NON-FINAL ACTION E-MAILED
Aug 8, 2019 GNRT
NON-FINAL ACTION WRITTEN
Aug 8, 2019 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 16, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 16, 2019 CRFA
ASSIGNED TO LIE
Jul 14, 2019 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 9, 2019 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 10, 2019 GNRN
NON-FINAL ACTION E-MAILED
Jan 10, 2019 GNRT
NON-FINAL ACTION WRITTEN
Jan 10, 2019 CNRT
ASSIGNED TO EXAMINER
Jan 3, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 28, 2018 NWOS
NEW APPLICATION ENTERED
Sep 25, 2018 NWAP

Related Trademarks

More from this Owner

NANOINJECT

NANOINJECT

NANOINJECT

NANOINJECT

IMMUNICOM

IMMUNICOM

IMMUNICOM

IMMUNICOM

IMMUNICOM

IMMUNICOM